These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1290 related articles for article (PubMed ID: 25398489)

  • 1. IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
    Mitra A; Raychaudhuri SK; Raychaudhuri SP
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():21-33. PubMed ID: 25398489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of IL-17 in psoriasis and psoriatic arthritis.
    Raychaudhuri SP
    Clin Rev Allergy Immunol; 2013 Apr; 44(2):183-93. PubMed ID: 22362575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic role of IL-17 in psoriasis and psoriatic arthritis.
    Chiricozzi A
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():9-20. PubMed ID: 25398488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis.
    Raychaudhuri SK; Saxena A; Raychaudhuri SP
    Clin Rheumatol; 2015 Jun; 34(6):1019-23. PubMed ID: 25939522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 17A: toward a new understanding of psoriasis pathogenesis.
    Lynde CW; Poulin Y; Vender R; Bourcier M; Khalil S
    J Am Acad Dermatol; 2014 Jul; 71(1):141-50. PubMed ID: 24655820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies.
    Novelli L; Chimenti MS; Chiricozzi A; Perricone R
    Autoimmun Rev; 2014 Jan; 13(1):64-9. PubMed ID: 24021172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of brodalumab for the treatment of psoriasis and psoriatic arthritis.
    Kivelevitch DN; Menter A
    Immunotherapy; 2015; 7(4):323-33. PubMed ID: 25917624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis.
    Kirkham BW; Kavanaugh A; Reich K
    Immunology; 2014 Feb; 141(2):133-42. PubMed ID: 23819583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases.
    Toussirot E
    Inflamm Allergy Drug Targets; 2012 Apr; 11(2):159-68. PubMed ID: 22280236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis.
    Mudigonda P; Mudigonda T; Feneran AN; Alamdari HS; Sandoval L; Feldman SR
    Dermatol Online J; 2012 Oct; 18(10):1. PubMed ID: 23122008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of IL-17 in the Pathogenesis of Psoriasis and Update on IL-17 Inhibitors for the Treatment of Plaque Psoriasis.
    AbuHilal M; Walsh S; Shear N
    J Cutan Med Surg; 2016 Nov; 20(6):509-516. PubMed ID: 27207350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-17 in psoriasis. The final frontier or just another brick in the wall?
    Carrascosa JM; Puig L
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():6-8. PubMed ID: 25398487
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of IL-17 in psoriasis.
    Malakouti M; Brown GE; Wang E; Koo J; Levin EC
    J Dermatolog Treat; 2015 Feb; 26(1):41-4. PubMed ID: 24552504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine-based therapy in psoriasis.
    Mitra A; Fallen RS; Lima HC
    Clin Rev Allergy Immunol; 2013 Apr; 44(2):173-82. PubMed ID: 22426927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of IL-17 and IL-22 in autoimmunity and cancer.
    Blake SJ; Teng MW
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():41-50. PubMed ID: 25398491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.
    Zhu S; Qian Y
    Clin Sci (Lond); 2012 Jun; 122(11):487-511. PubMed ID: 22324470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-IL-17 Medications Used in the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review.
    Canavan TN; Elmets CA; Cantrell WL; Evans JM; Elewski BE
    Am J Clin Dermatol; 2016 Feb; 17(1):33-47. PubMed ID: 26649440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scid mouse model of psoriasis: a unique tool for drug development of autoreactive T-cell and th-17 cell-mediated autoimmune diseases.
    Raychaudhuri SK; Raychaudhuri SP
    Indian J Dermatol; 2010; 55(2):157-60. PubMed ID: 20606886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis.
    Mease PJ
    Curr Opin Rheumatol; 2015 Mar; 27(2):127-33. PubMed ID: 25599143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and early clinical data on IL-17 blockade in psoriasis.
    Nwe SM; Champlain AH; Gordon KB
    Expert Rev Clin Immunol; 2013 Jul; 9(7):677-82. PubMed ID: 23899238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.